Cargando…

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients

BACKGROUND: Distinction in the mutational profile between the common histological types, lung adenocarcinoma (LUAD) and squamous cell lung carcinoma (LUSC) has been well‐established. However, comprehensive mutation profiles of the predominant histological subtypes within LUAD and LUSC remains elusiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Ying, Zhang, Lihua, Guo, Lingchuan, Wu, Chunyan, Zhou, Jianhua, Zhou, Yongchun, Ma, Jie, Li, Xiao, Ji, Pan, Wang, Ming, Zhu, Weidong, Shi, Chenxi, Li, Sanen, Wu, Wei, Zhu, Wei, Xiao, Desheng, Fu, Chunyan, He, Qiuyan, Sun, Rui, Mao, Xinru, Lizaso, Analyn, Li, Bing, Han‐Zhang, Han, Zhang, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938761/
https://www.ncbi.nlm.nih.gov/pubmed/31692283
http://dx.doi.org/10.1111/1759-7714.13208
_version_ 1783484092139962368
author Ding, Ying
Zhang, Lihua
Guo, Lingchuan
Wu, Chunyan
Zhou, Jianhua
Zhou, Yongchun
Ma, Jie
Li, Xiao
Ji, Pan
Wang, Ming
Zhu, Weidong
Shi, Chenxi
Li, Sanen
Wu, Wei
Zhu, Wei
Xiao, Desheng
Fu, Chunyan
He, Qiuyan
Sun, Rui
Mao, Xinru
Lizaso, Analyn
Li, Bing
Han‐Zhang, Han
Zhang, Zhihong
author_facet Ding, Ying
Zhang, Lihua
Guo, Lingchuan
Wu, Chunyan
Zhou, Jianhua
Zhou, Yongchun
Ma, Jie
Li, Xiao
Ji, Pan
Wang, Ming
Zhu, Weidong
Shi, Chenxi
Li, Sanen
Wu, Wei
Zhu, Wei
Xiao, Desheng
Fu, Chunyan
He, Qiuyan
Sun, Rui
Mao, Xinru
Lizaso, Analyn
Li, Bing
Han‐Zhang, Han
Zhang, Zhihong
author_sort Ding, Ying
collection PubMed
description BACKGROUND: Distinction in the mutational profile between the common histological types, lung adenocarcinoma (LUAD) and squamous cell lung carcinoma (LUSC) has been well‐established. However, comprehensive mutation profiles of the predominant histological subtypes within LUAD and LUSC remains elusive. METHODS: We analyzed the mutational profile of 318 Chinese NSCLC patients of adenocarcinoma and squamous cell carcinoma predominant subtypes from seven hospitals using capture‐based ultra‐deep sequencing of 68 lung cancer‐related genes. RESULTS: Of the 318 NSCLC patients, 215 were diagnosed with LUAD and 103 with LUSC. Adenocarcinoma in situ and acinar adenocarcinoma were the most predominant subtypes of LUAD. On the other hand, keratinizing squamous cell carcinoma was the most predominant subtype of LUSC. Among the LUAD subtypes, EGFR sensitizing mutations were most prevalent in the invasive lepidic subtype. More than half of the patients with preinvasive adenocarcinoma in situ, minimally invasive, acinar, micropapillary and papillary subtypes were also EGFR‐mutants. Patients with colloidal, invasive mucinous, and fetal subtypes had the least number of EGFR mutations. Moreover, KRAS mutations were prevalent in patients with invasive mucinous, colloid, enteric and solid subtypes. A total of 90% of the LUSC patients harbor mutations in TP53, wherein all patients except five with nonkeratinizing were TP53 mutants. PIK3CA amplifications were most prevalent in keratinizing, followed by basaloid and nonkeratinizing subtypes. CONCLUSION: These data suggest that the mutational profiles among the predominant histological subtypes were very distinct, which provided a reliable tool to improve treatment decisions.
format Online
Article
Text
id pubmed-6938761
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-69387612020-01-06 Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients Ding, Ying Zhang, Lihua Guo, Lingchuan Wu, Chunyan Zhou, Jianhua Zhou, Yongchun Ma, Jie Li, Xiao Ji, Pan Wang, Ming Zhu, Weidong Shi, Chenxi Li, Sanen Wu, Wei Zhu, Wei Xiao, Desheng Fu, Chunyan He, Qiuyan Sun, Rui Mao, Xinru Lizaso, Analyn Li, Bing Han‐Zhang, Han Zhang, Zhihong Thorac Cancer Original Articles BACKGROUND: Distinction in the mutational profile between the common histological types, lung adenocarcinoma (LUAD) and squamous cell lung carcinoma (LUSC) has been well‐established. However, comprehensive mutation profiles of the predominant histological subtypes within LUAD and LUSC remains elusive. METHODS: We analyzed the mutational profile of 318 Chinese NSCLC patients of adenocarcinoma and squamous cell carcinoma predominant subtypes from seven hospitals using capture‐based ultra‐deep sequencing of 68 lung cancer‐related genes. RESULTS: Of the 318 NSCLC patients, 215 were diagnosed with LUAD and 103 with LUSC. Adenocarcinoma in situ and acinar adenocarcinoma were the most predominant subtypes of LUAD. On the other hand, keratinizing squamous cell carcinoma was the most predominant subtype of LUSC. Among the LUAD subtypes, EGFR sensitizing mutations were most prevalent in the invasive lepidic subtype. More than half of the patients with preinvasive adenocarcinoma in situ, minimally invasive, acinar, micropapillary and papillary subtypes were also EGFR‐mutants. Patients with colloidal, invasive mucinous, and fetal subtypes had the least number of EGFR mutations. Moreover, KRAS mutations were prevalent in patients with invasive mucinous, colloid, enteric and solid subtypes. A total of 90% of the LUSC patients harbor mutations in TP53, wherein all patients except five with nonkeratinizing were TP53 mutants. PIK3CA amplifications were most prevalent in keratinizing, followed by basaloid and nonkeratinizing subtypes. CONCLUSION: These data suggest that the mutational profiles among the predominant histological subtypes were very distinct, which provided a reliable tool to improve treatment decisions. John Wiley & Sons Australia, Ltd 2019-11-06 2020-01 /pmc/articles/PMC6938761/ /pubmed/31692283 http://dx.doi.org/10.1111/1759-7714.13208 Text en © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ding, Ying
Zhang, Lihua
Guo, Lingchuan
Wu, Chunyan
Zhou, Jianhua
Zhou, Yongchun
Ma, Jie
Li, Xiao
Ji, Pan
Wang, Ming
Zhu, Weidong
Shi, Chenxi
Li, Sanen
Wu, Wei
Zhu, Wei
Xiao, Desheng
Fu, Chunyan
He, Qiuyan
Sun, Rui
Mao, Xinru
Lizaso, Analyn
Li, Bing
Han‐Zhang, Han
Zhang, Zhihong
Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
title Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
title_full Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
title_fullStr Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
title_full_unstemmed Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
title_short Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
title_sort comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in chinese non‐small cell lung cancer patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938761/
https://www.ncbi.nlm.nih.gov/pubmed/31692283
http://dx.doi.org/10.1111/1759-7714.13208
work_keys_str_mv AT dingying comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT zhanglihua comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT guolingchuan comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT wuchunyan comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT zhoujianhua comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT zhouyongchun comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT majie comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT lixiao comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT jipan comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT wangming comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT zhuweidong comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT shichenxi comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT lisanen comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT wuwei comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT zhuwei comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT xiaodesheng comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT fuchunyan comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT heqiuyan comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT sunrui comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT maoxinru comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT lizasoanalyn comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT libing comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT hanzhanghan comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients
AT zhangzhihong comparativestudyonthemutationalprofileofadenocarcinomaandsquamouscellcarcinomapredominanthistologicsubtypesinchinesenonsmallcelllungcancerpatients